John P. Shannon
Net Worth

Last updated:

What is John P. Shannon net worth?

The estimated net worth of Mr. John P. Shannon is at least $14,193,000 as of 17 Nov 2023. He owns shares worth $10,312,600 as insider and has received compensation worth at least $3,880,400 in Xeris Biopharma Holdings, Inc..

What is the salary of John P. Shannon?

Mr. John P. Shannon salary is $776,080 per year as Pres, Chief Operating Officer & Director in Xeris Biopharma Holdings, Inc..

How old is John P. Shannon?

Mr. John P. Shannon is 63 years old, born in 1962.

What stocks does John P. Shannon currently own?

As insider, Mr. John P. Shannon owns shares in one company:

Company Title Shares Price per share Total value
Xeris Biopharma Holdings, Inc. (XERS) Pres, Chief Operating Officer & Director 1,408,575 $7.32 $10,312,600

What does Xeris Biopharma Holdings, Inc. do?

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

XERS logo
XERS
Xeris Biopharma Holdings, Inc.
$7.32

John P. Shannon insider trading

Xeris Biopharma Holdings, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 30,769 $1.64 $50,400
Purchase
Common Stock 60,000 $2.1 $126,000
Purchase
Common Stock 40,000 $2.09 $83,520
Purchase
Common Stock 22,000 N/A N/A
Purchase
Common Stock 7,886 N/A N/A
Purchase
Common Stock 12,048 N/A N/A

Xeris Biopharma Holdings key executives

Xeris Biopharma Holdings, Inc. executives and other stock owners filed with the SEC: